Search Results - "MILOJKOVIC, D"

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia by Steegmann, J L, Baccarani, M, Breccia, M, Casado, L F, García-Gutiérrez, V, Hochhaus, A, Kim, D-W, Kim, T D, Khoury, H J, Le Coutre, P, Mayer, J, Milojkovic, D, Porkka, K, Rea, D, Rosti, G, Saussele, S, Hehlmann, R, Clark, R E

“…Most reports on chronic myeloid leukaemia (CML) treatment with tyrosine kinase inhibitors (TKIs) focus on efficacy, particularly on molecular response and…”
Get full text

Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy by Robertson, H F, Milojkovic, D, Butt, N, Byrne, J, Claudiani, S, Copland, M, Gallipoli, P, Innes, A J, Knight, K, Mahdi, A J, Parker, J, Virchis, A, Apperley, J F

“…Diagnosing chronic myeloid leukaemia (CML) during pregnancy is rare. Tyrosine kinase inhibitors (TKIs) have traditionally been contraindicated owing to their…”
Get full text

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease by Horne, G. A., Stobo, J., Kelly, C., Mukhopadhyay, A., Latif, A. L., Dixon-Hughes, J., McMahon, L., Cony-Makhoul, P., Byrne, J., Smith, G., Koschmieder, S., BrÜmmendorf, T. H., Schafhausen, P., Gallipoli, P., Thomson, F., Cong, W., Clark, R. E., Milojkovic, D., Helgason, G. V., Foroni, L., Nicolini, F. E., Holyoake, T. L., Copland, M.

“…In chronic-phase chronic myeloid leukaemia (CP-CML), residual BCR-ABL1 + leukaemia stem cells are responsible for disease persistence despite TKI. Based on in…”
Get full text

In vitro safety assessment of the strawberry tree (Arbutus unedo L.) water leaf extract and arbutin in human peripheral blood lymphocytes by Jurica, K., Brčić Karačonji, I., Mikolić, A., Milojković-Opsenica, D., Benković, V., Kopjar, N.

“…Strawberry tree ( Arbutus unedo L.) leaves have long been used in the traditional medicine of the Mediterranean region. One of their most bioactive…”
Get full text

Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease by Boban, Milojkovic, Kocic, Gordana, Radenkovic, Sonja, Pavlovic, Radmila, Cvetkovic, Tatjana, Deljanin-Ilic, Marina, Ilic, Stevan, Bobana, Milojkovic D, Djindjic, Boris, Stojanovic, Dijana, Sokolovic, Dusan, Jevtovic-Stoimenov, Tatjana

“…Purine nucleotide liberation and their metabolic rate of interconversion may be important in the development of hypertension and its renal consequences. In the…”
Get more information

Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation by Pavlů, J, Auner, H W, Szydlo, R M, Sevillano, B, Palani, R, O'Boyle, F, Chaidos, A, Jakob, C, Kanfer, E, MacDonald, D, Milojkovic, D, Rahemtulla, A, Bradshaw, A, Olavarria, E, Apperley, J F, Pello, O M

“…Hematopoietic precursor cells (HPC) are able to restore hematopoiesis after high-dose chemotherapy and their cryopreservation is routinely employed prior to…”
Get full text

Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host by DE LAVALLADE, Hugues, GARLAND, Paula, MACDONALD, Donald, KELLEHER, Peter, COOPER, Nichola, KHODER, Ahmad, GABRIEL, Ian H, MILOJKOVIC, Dragana, PAVLU, Jiri, GOLDMAN, John M, APPERLEY, Jane F, REZVANI, Katayoun, SEKINE, Takuya, HOSCHLER, Katja, MARIN, David, STRINGARIS, Kate, LOUCAIDES, Eva, HOWE, Katherine, SZYDLO, Richard, KANFER, Ed

“…In 2009 the declaration by the World Health Organization of a global pandemic of influenza-H1N1 virus led to a vaccination campaign to ensure protection for…”
Get full text

P714: EFFECT OF TYROSINE KINASE INHIBITORS ON MALE FERTILITY IN PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKAEMIA by Nesr, G., Claudiani, S., Milojkovic, D., Caballes, I., Lovato, S., Channa, J., Apperley, J. F.

Get full text

Hypereosinophilic syndrome: an indolent rash with a serious cardiac complication by Merika, E. E., Lefroy, D., Milojkovic, D., Wakelin, S. H.

“…Summary Idiopathic hypereosinophilic syndrome (HES) is a rare disorder, characterized by prominent blood or tissue eosinophilia with ensuing tissue damage,…”
Get full text

P713: REAL‐WORLD MANAGEMENT OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML): FIRST ANALYSIS FROM THE UK NATIONAL REGISTRY FOR CML by Nesr, G., Szydlo, R., Braithwaite, B., Frackelton, S., Mathew, P., Hashmi, M., Fernando, F., Innes, A., Claudiani, S., Khan, A., Rao, A., Foroni, L., Milojkovic, D., Apperley, J. F., Clark, R. E.

Get full text

P717: BOSUTINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA: GASTROINTESTINAL, LIVER, EFFUSION AND RENAL SAFETY CHARACTERIZATION IN THE BFORE TRIAL by Cortes, J. E., Milojkovic, D., Gambacorti‐Passerini, C., García‐Gutiérrez, V., Mauro, M. J., Leip, E., Purcell, S., Viqueira, A., Brümmendorf, T. H.

Get full text

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib by Marin, D, Gabriel, I H, Ahmad, S, Foroni, L, Lavallade, H de, Clark, R, O'Brien, S, Sergeant, R, Hedgley, C, Milojkovic, D, Khorashad, J S, Bua, M, Alsuliman, A, Khoder, A, Stringaris, K, Cooper, N, Davis, J, Goldman, J M, Apperley, J F, Rezvani, K

“…Natural killer (NK) cells are expanded in chronic myeloid leukemia (CML) patients on tyrosine kinase inhibitors (TKI) and exert cytotoxicity. The inherited…”
Get full text

Authentication of the botanical origin of unifloral honey by infrared spectroscopy coupled with support vector machine algorithm by Lenhardt, L, Zekovi, I, Drami anin, T, Teši, Milojkovi -Opsenica, D, Drami anin, M D

“…In recent years, the potential of Fourier-transform infrared spectroscopy coupled with different chemometric tools in food analysis has been established. This…”
Get full text

P706: ASCIMINIB USE IN CML: THE UK EXPERIENCE by Innes, A., Orovboni, V., Claudiani, S., Fernando, F., Khan, A., Byrne, J., Gallipoli, P., Copland, M., Horne, G., Arnold, C., Collins, A., Cunningham, N., Danga, A., Frewin, R., Garland, P., Hannah, G., Hassan, S., Makkuni, S., Rothwell, K., Foroni, L., Hayden, C., Apperley, J., Milojkovic, D.

Get full text

hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia by Bazeos, A, Marin, D, Reid, A G, Gerrard, G, Milojkovic, D, May, P C, de Lavallade, H, Garland, P, Rezvani, K, Apperley, J F, Goldman, J M, Foroni, L, Khorashad, J S

Get full text

Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT by Innes, A J, Beattie, R, Sergeant, R, Damaj, G, Foroni, L, Marin, D, Kanfer, E, Mielke, S, Milojkovic, D, MacDonald, D, Pavlu, J, Rahemtulla, A, Roberts, I, Slade, D, Bray, E, Goldman, J, Apperley, J, Szydlo, R, Dazzi, F, Rezvani, K

“…Although the feasibility of using HLA-mismatched unrelated donors as an alternate graft source for haematopoietic SCT (HSCT) has been shown, little is known…”
Get full text

Microenvironment Produced by Acute Myeloid Leukemia Cells Prevents T Cell Activation and Proliferation by Inhibition of NF-κB, c-Myc, and pRb Pathways by Buggins, Andrea G. S., Milojkovic, Dragana, Arno, Matthew J., Lea, Nicholas C., Mufti, Ghulam J., Thomas, N. Shaun B., Hirst, William J. R.

“…Abstract Tumors produce a variety of immunosuppressive factors which can prevent the proliferation and maturation of a number of normal hemopoietic cell types…”
Get full text

Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy by Milojković, D, Aldouri, M, Pagliuca, A, Mufti, G J, Devereux, S

Get full text

Analysis of Via Capacitance in Arbitrary Multilayer PCBs by Pajovic, M., Jinghan Yu, Milojkovic, D.

“…The signal layer transitions at regions of multilayer printed circuit boards, where high-speed signal lines switch between two signal layers, may affect the…”
Get full text

A new rapid and sensitive assay for detecting the T315I BCR-ABL kinase domain mutation in chronic myeloid leukaemia by Khorashad, J S, Thelwell, N, Milojkovic, D, Marin, D, Watson, J A, Goldman, J M, Apperley, J F, Foroni, L, Reid, A G

“…A significant minority of chronic myeloid leukaemia patients eventually develop resistance to imatinib, often as a result of point mutations within the BCR-ABL…”
Get more information